Evolent Financial Statements From 2010 to 2024

EVH Stock  USD 29.26  0.87  2.89%   
Evolent Health financial statements provide useful quarterly and yearly information to potential Evolent Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Evolent Health financial statements helps investors assess Evolent Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Evolent Health's valuation are summarized below:
Gross Profit
316.6 M
Profit Margin
(0.06)
Market Capitalization
3.4 B
Enterprise Value Revenue
1.9775
Revenue
B
We have found one hundred twenty available fundamental signals for Evolent Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Evolent Health prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. Enterprise Value is estimated to decrease to about 742.8 M

Evolent Health Total Revenue

2.06 Billion

Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Interest Expense of 56.9 M or Selling General Administrative of 236.7 M, as well as many exotic indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0049 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
  
This module can also supplement Evolent Health's financial leverage analysis and stock options assessment as well as various Evolent Health Technical models . Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B2.7 B1.1 B
Slightly volatile
Other Current Liabilities640.8 M610.3 M177.4 M
Slightly volatile
Total Current Liabilities708 M674.2 M229.7 M
Slightly volatile
Other Liabilities71.7 M63.8 M53.2 M
Slightly volatile
Property Plant And Equipment Net92.7 M90.2 M66.1 M
Slightly volatile
Current Deferred Revenue5.7 MM15 M
Slightly volatile
Accounts Payable53.1 M48.2 M39.3 M
Slightly volatile
Cash191.9 M192.8 M154.3 M
Slightly volatile
Non Current Assets TotalBB742.7 M
Slightly volatile
Other Assets65.6 M33 M49.3 M
Slightly volatile
Cash And Short Term Investments215.3 M192.8 M168.8 M
Slightly volatile
Net Receivables469.1 M446.7 M118.6 M
Slightly volatile
Common Stock Shares Outstanding76.8 M111.3 M63.9 M
Slightly volatile
Short Term Investments25.7 M13.8 M18.9 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B2.7 B1.1 B
Slightly volatile
Non Current Liabilities Total985.3 M938.4 M287.3 M
Slightly volatile
Other Current Assets28.8 M30.3 M131.2 M
Slightly volatile
Total Liabilities1.7 B1.6 B520.1 M
Slightly volatile
Property Plant And Equipment Gross139.8 M248.7 M97.8 M
Slightly volatile
Total Current Assets385.8 M683.7 M298.9 M
Slightly volatile
Intangible Assets789.6 M752 M256.4 M
Slightly volatile
Property Plant Equipment60.1 M101.1 M50 M
Slightly volatile
Good Will707.6 M1.1 B638.4 M
Pretty Stable
Common Stock Total Equity791.4 K1.2 M562.5 K
Slightly volatile
Deferred Long Term Liabilities4.1 M4.3 M12.9 M
Slightly volatile
Long Term Investments4.7 M4.9 M28.5 M
Pretty Stable
Common Stock839.2 K1.2 M564.8 K
Slightly volatile
Noncontrolling Interest In Consolidated Entity5.7 MM136 M
Slightly volatile
Capital Surpluse1.1 B1.7 B845.7 M
Slightly volatile
Non Current Liabilities Other3.5 M3.6 M25.6 M
Slightly volatile
Short and Long Term Debt Total356.5 M644.8 M244.7 M
Slightly volatile
Long Term Debt Total259 M474.9 M206.9 M
Slightly volatile
Short and Long Term Debt22.7 M23.9 M76.2 M
Slightly volatile
Cash And Equivalents231.9 M216.4 M182.1 M
Slightly volatile
Net Invested Capital1.3 B1.7 B1.2 B
Slightly volatile
Net Working CapitalM9.4 M167 M
Slightly volatile
Capital StockM1.2 M881.1 K
Slightly volatile
Capital Lease Obligations51.3 M47.7 M69.9 M
Slightly volatile

Evolent Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization129.6 M123.4 M40.7 M
Slightly volatile
Selling General Administrative236.7 M358.1 M176.7 M
Slightly volatile
Total Revenue2.1 BB651.4 M
Slightly volatile
Other Operating Expenses2.1 BB686 M
Slightly volatile
Research Development16.2 M26.7 M12.3 M
Slightly volatile
Cost Of Revenue1.6 B1.5 B466.2 M
Slightly volatile
Non Recurring197.3 M247.4 M187.6 M
Slightly volatile
Interest Income4.9 M5.3 M13.3 M
Slightly volatile
Reconciled Depreciation70.7 M123.4 M49.8 M
Slightly volatile

Evolent Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation21.6 M40.5 M15.6 M
Slightly volatile
Begin Period Cash Flow252.4 M215.2 M175 M
Slightly volatile
Depreciation129.6 M123.4 M41.1 M
Slightly volatile
Capital Expenditures26.8 M28.7 M21.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.781.87119.0635
Slightly volatile
Dividend Yield0.00490.00510.0567
Slightly volatile
Days Sales Outstanding74.0683.030684.8556
Slightly volatile
Invested Capital0.630.60390.3479
Slightly volatile
Stock Based Compensation To Revenue0.01960.02060.0399
Pretty Stable
EV To Sales2.02.10128.2029
Slightly volatile
Payables Turnover32.7231.161713.605
Slightly volatile
Sales General And Administrative To Revenue0.550.280.5107
Slightly volatile
Research And Ddevelopement To Revenue0.01960.01360.0213
Slightly volatile
Cash Per Share3.621.8573.1989
Very volatile
Days Payables Outstanding11.1311.713151.5332
Pretty Stable
Intangibles To Total Assets0.420.69710.4119
Slightly volatile
Current Ratio0.961.0142.0152
Slightly volatile
Receivables Turnover5.054.3965.3455
Slightly volatile
Graham Number24.5514.812518.6241
Pretty Stable
Debt To Equity0.630.60390.3479
Slightly volatile
Revenue Per Share18.5417.65287.6266
Slightly volatile
Interest Debt Per Share6.66.28312.5323
Slightly volatile
Debt To Assets0.140.24060.1469
Slightly volatile
Days Of Payables Outstanding11.1311.713151.5332
Pretty Stable
Long Term Debt To Capitalization0.210.3730.2092
Slightly volatile
Total Debt To Capitalization0.20.37650.233
Slightly volatile
Debt Equity Ratio0.630.60390.3479
Slightly volatile
Quick Ratio1.910.9692.0181
Slightly volatile
Net Income Per E B T0.90.55850.8716
Slightly volatile
Cash Ratio0.270.2861.4327
Slightly volatile
Days Of Sales Outstanding74.0683.030684.8556
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.50.79841.8341
Pretty Stable
Fixed Asset Turnover22.8721.77828.0961
Slightly volatile
Debt Ratio0.140.24060.1469
Slightly volatile
Price Sales Ratio1.781.87119.0635
Slightly volatile
Asset Turnover0.380.73270.3942
Slightly volatile

Evolent Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap772.9 M765.9 M698.1 M
Very volatile
Enterprise Value742.8 M749.4 M669.3 M
Slightly volatile

Evolent Fundamental Market Drivers

Forward Price Earnings21.7391
Cash And Short Term Investments192.8 M

Evolent Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Evolent Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Evolent Health income statement, its balance sheet, and the statement of cash flows. Evolent Health investors use historical funamental indicators, such as Evolent Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolent Health investors may use each financial statement separately, they are all related. The changes in Evolent Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolent Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evolent Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evolent Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM5.7 M
Total RevenueB2.1 B
Cost Of Revenue1.5 B1.6 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.28  0.55 
Research And Ddevelopement To Revenue 0.01  0.02 
Capex To Revenue(0.01)(0.02)
Revenue Per Share 17.65  18.54 
Ebit Per Revenue(0.04)(0.04)

Evolent Health Investors Sentiment

The influence of Evolent Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Evolent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Evolent Health's public news can be used to forecast risks associated with an investment in Evolent. The trend in average sentiment can be used to explain how an investor holding Evolent can time the market purely based on public headlines and social activities around Evolent Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Evolent Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Evolent Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Evolent Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Evolent Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Evolent Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Evolent Health's short interest history, or implied volatility extrapolated from Evolent Health options trading.

Pair Trading with Evolent Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Evolent Stock

  0.74FONR FonarPairCorr
  0.64CNC Centene Corp Earnings Call TomorrowPairCorr

Moving against Evolent Stock

  0.46IRIX IRIDEX Financial Report 9th of May 2024 PairCorr
  0.42HSDT Helius Medical Techn Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.
The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.28)
Revenue Per Share
17.653
Quarterly Revenue Growth
0.454
Return On Assets
0.0086
Return On Equity
(0.11)
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.